CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function.
The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
糖酵解,包括乳酸发酵和丙酮酸氧化,协调CD8+ T细胞分化。然而,由线粒体丙酮酸载体(MPC)控制的线粒体丙酮酸代谢和摄取如何影响T细胞功能和命运仍不清楚。我们发现,MPC的基因缺失驱动CD8+ T细胞向记忆表型分化。MPC抑制诱导的代谢灵活性促进了谷氨酰胺和脂肪酸氧化产生乙酰辅酶A,从而导致促记忆基因上组蛋白乙酰化和染色质可及性增强。然而,在肿瘤微环境中,MPC对于维持乳酸氧化以支持CD8+ T细胞抗肿瘤功能至关重要。我们进一步揭示,使用MPC抑制剂进行嵌合抗原受体(CAR)T细胞制造可印记记忆表型,并证明输注经MPC抑制剂处理的CAR-T 细胞可产生更优且持久的抗肿瘤活性。总之,我们揭示了线粒体丙酮酸摄取指导代谢灵活性以引导T细胞分化和抗肿瘤反应。
Glycolysis, including both lactate fermentation and pyruvate oxidation, orchestrates CD8 + T cell differentiation.
However, how mitochondrial pyruvate metabolism and uptake controlled by the mitochondrial pyruvate carrier (MPC) impact T cell function and fate remains elusive.
We found that genetic deletion of MPC drives CD8 + T cell differentiation toward a memory phenotype. Metabolic flexibility induced by MPC inhibition facilitated acetyl-coenzyme-A production by glutamine and fatty acid oxidation that results in enhanced histone acetylation and chromatin accessibility on pro-memory genes.
However, in the tumor microenvironment, MPC is essential for sustaining lactate oxidation to support CD8 + T cell antitumor function.
We further revealed that chimeric antigen receptor (CAR) T cell manufacturing with an MPC inhibitor imprinted a memory phenotype and demonstrated that infusing MPC inhibitor-conditioned CAR T cells resulted in superior and long-lasting antitumor activity. Altogether, we uncover that mitochondrial pyruvate uptake instructs metabolic flexibility for guiding T cell differentiation and antitumor responses.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。